According to Hong Seng's filing with Bursa Malaysia, Pow Pocket's Jengu platform operates a web portal, johortravelsafe.my, which has the capability to register travellers into and out of Johor.
The platform is currently being utilised for the arrangement of medical screening of Covid-19 via the Reverse Transcription Polymerase Chain Reaction testing and Antigen Rapid Test Kit for such travellers.
Via the Jengu platform, the joint venture company, Neogenix Sdn Bhd, will tender for the provision of online registration of inbound travellers for medical screening at immigration points at the Sultan Iskandar Buildings located at the northern end of the Johor-Singapore Causeway and Sultan Abu Bakar Complex at the northern end of the Malaysia-Singapore Second Link.
The JV will also tender for the provision of quarantine and related services incuding the Reciprocal Green Lane, Periodic Commuting Agreement and Daily Commuting Arrangement travel schemes.
HS Bio will pay RM9mil cash to Pow Pocket for 60% ownership of the Johor portion of the Jengu platform including the website.
Pow Pocket will retain ownership of the remaining 40% stake.
Under the agreement, the collaboration will be for an initial term of five years from the date of the project with an option to extend upon mutual agreement from the parties.
"The joint venture is part of the continuous initiatives of Hong Seng Group to widen its healthcare segment’s contribution to the overall financial performance of the Group, subsequent to the diversification into the business of supply of healthcare products and services," said Hong Seng.